Comparison · NCT00023595-69f4eadc
Total H02: Medication+CABG vs H02: Medication+CABG+SVR: H02: All-cause Mortality or Revascularization (CABG or PCI)
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Total H02: Medication+CABG vs H02: Medication+CABG+SVR: H02: All-cause Mortality or Revascularization (CABG or PCI). Trial comparisons, record NCT00023595-69f4eadc. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00023595-69f4eadc
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.349 | 0.308 | 0.392 | wilson | |
| Risk in group 2 | 0.303 | 0.265 | 0.345 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0453 | -0.0128 | 0.103 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.15 | 0.961 | 1.37 | log | |
| Odds ratio, group 1 over group 2 | 1.23 | 0.943 | 1.6 | log | |
| Number needed to treat, for one more participant with the outcome on Total H02: Medication+CABG than on H02: Medication+CABG+SVR | 22.1 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Total H02: Medication+CABG | H02 patients were randomized to medical therapy plus CABG arm. In addition to the guideline-recommended medications, coronary artery bypass graft (CABG) surgery was to be performed for patients randomized to this treatment arm.~The Total H02: Medication + CABG group includes the H02: Medication + CABG group and those 76 patients who belong to H01+H02: Medication + CABG arm. | 174 | 499 | OG000 |
| Group 2 | H02: Medication+CABG+SVR | 50% of H02 patients were randomized to this medical therapy plus CABG plus SVR arm. In addition to the guideline-recommended medications, both the coronary artery bypass graft (CABG) surgery and the surgical ventricular reconstruction (SVR) were to be performed for patients randomized to this treatment arm. | 152 | 501 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- H02: All-cause Mortality or Revascularization (CABG or PCI)
- Description
- CABG = coronary artery bypass grafting. For patients randomized to CABG or CABG +SVR group, this represents the repeat CABG received during follow-up. PCI = Percutaneous Coronary Intervention.
- Time frame
- 5 years post randomization
- Population
- The Total H02: Medication + CABG group includes the H02: Medication + CABG group and those 76 patients who belong to H01+H02: Medication + CABG arm.
Source ClinicalTrials.gov
Trial
- Title
- Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
- NCT number
- NCT00023595
- Phases
- PHASE3
- Conditions
- Cardiovascular Diseases, Coronary Disease, Heart Failure, Congestive, Heart Diseases
- Interventions
- CABG surgery plus MED, Active Medication Alone, CABG plus MED and SVR
- Lead sponsor
- Duke University
- Results first posted
- 2017-07-24
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00023595?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00023595-69f4eadc